Those manufacturers can then sell those medicines at much lower cost to people who need access to them, to treatment programs that need access to them.
Acei producători pot vinde apoi acele medicamente la un preț mult mai mic celor care au nevoie de ele sau programelor de tratament care au nevoie de ele.